Skip to content
  • Reports
  • Podcast
  • Log In

Now covering the global biotech industry!
Read More
Topics
  • CRISPR
  • CAR-T
  • Covid-19
  • Microbiome
  • mRNA technology
  • Gene therapy
  • CRISPR
  • CAR-T
  • Covid-19
  • Microbiome
  • mRNA technology
  • Gene therapy
  • Log In
Now covering the global biotech industry!
Read More

Home » What’s new » Idorsia

Idorsia

ADVERTISEMENT
Best in Biotech

The Billion-Euro European Biotech Companies in 2022

Here’s a list of the public European biotech companies that are worth more than a…

By Larissa Warneck-Silvestrin
20/12/2021 - 12 minutes
Best in Biotech

A Year to Remember: The Biggest European Biotech News in 2020

The Covid-19 pandemic caused huge disruption for European biotech in 2020, but the industry pulled…

By Jonathan Smith
28/12/2020 - 12 minutes
News and Trends

Idorsia’s Drug Improves Sleep in First Phase III Trial for Insomnia

The Swiss pharmaceutical company Idorsia has announced that its drug candidate daridorexant significantly improved sleep…

By Karen O’Hanlon Cohrt
21/04/2020 - 3 minutes
News and Trends

Top Cardiology Biotech News from the ESC Conference 2019

Many cardiology companies and academics gathered in Paris earlier this week to showcase their latest…

By Jonathan Smith
05/09/2019 - 4 minutes
Best in Biotech

The Top 20 Women in Leading Biotech Roles in Europe

The biotech industry has often been criticized for its lack of gender diversity. While there…

By Jonathan Smith
21/05/2019 - 12 minutes
More News!

Swiss Biotech Tackles Brain Artery Constriction Caused by Hemorrhage

Idorsia will start a Phase III trial to study the efficacy of its drug in…

By Alexander Burik
18/06/2018 - 2 minutes
News and Trends

Actelion’s Billion-Euro Spin-Off Starts First Phase III Trial in its Pipeline

Idorsia has started the first Phase III study in its pipeline to test the drug…

By Alexander Burik
16/05/2018 - 3 minutes
Best in Biotech

Say Hello to the Top 14 Entrepreneurial Women in European Biotech

Today, March 8, is international women's day. To celebrate the achievements of women we're revisiting…

By Alex Dale
08/03/2018 - 8 minutes
News and Trends

How is Actelion Spin-Off Idorsia Doing One Year Later?

Actelion's spin-off Idorsia was blessed with a large pipeline and a healthy bank balance. How…

By Clara Rodríguez Fernández
01/03/2018 - 3 minutes
Best in Biotech

Happy 2018, Here Are the Top 9 European Biotech Companies To Watch

As the 2017 reports roll in, we're already turning our gaze to 2018. These are…

By Evelyn Warner
09/01/2018 - 5 minutes
News and Trends

Actelion Spin Out and Roche Join Forces to Develop Cancer Immunotherapies

Idorsia and Roche have agreed on a research collaboration, with the big pharma getting exclusive…

By Alex Dale
20/12/2017 - 2 minutes
News and Trends

Swiss Biotech Brings in Reinforcements to See Hypertension Drug Through Phase III

Idorsia will collaborate with Janssen on the development of its hypertension drug, aprocitentan, which could…

By Alex Dale
04/12/2017 - 3 minutes
footer logo

Labiotech.eu is the leading digital media covering the global biotech industry.

Over 150,000 monthly visitors use it to keep an eye on the business and innovations in biotechnology. Hope you’ll enjoy reading our stories!

  • About us
  • Inside Labiotech
  • Join Us
  • Advertise
  • Contact
  • Editorial Calendar
  • Site Map
  • Linkedin
  • Twitter
  • Youtube
  • RSS Feed
Made with in Berlin. Labiotech UG, All Rights Reserved -
  • Imprint
  • Privacy Policy

Browse Topics

Search for a topic, country or company name by using the search box

    Popular topics:


    CRISPR mRNA technology CAR-T HIV Cell therapy Diabetes Microbiome Startups Gene therapy Synthetic biology
    Labiotech.eu
    Log In Newsletter

    Topics

    • Gene Therapy
    • CRISPR
    • CAR-T
    • Covid-19
    • Microbiome
    • Diabetes
    • Cancer

    Sections

    • News and Trends
    • In Depth
    • Best in Biotech
    • Opinion
    • Interview
    • Infographics
    Show All Topics

    For Members

    • Expert Advice
    • Reports
    • Startup Scout

    More

    • About us
    • Inside Labiotech
    • Join Us
    • Advertise
    • Contact
    • Podcast